Paying users zone. Data is hidden behind hidden.

  • Get 1-month access to Bristol-Myers Squibb Co. for $17.99, or

  • get full access to the entire website for at least 3 months from $49.99.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey
Unlock

This is a one-time payment. There is no automatic renewal.

Microsoft Excel LibreOffice Calc

Bristol-Myers Squibb Co. (BMY)

Common-Size Income Statement

Beginner level

Bristol-Myers Squibb Co., common-size consolidated income statement

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Net product sales hidden hidden hidden hidden hidden
Alliance and other revenues hidden hidden hidden hidden hidden
Revenues hidden hidden hidden hidden hidden
Cost of products sold hidden hidden hidden hidden hidden
Gross margin hidden hidden hidden hidden hidden
Marketing, selling and administrative hidden hidden hidden hidden hidden
Research and development hidden hidden hidden hidden hidden
Operating income hidden hidden hidden hidden hidden
Interest expense hidden hidden hidden hidden hidden
Investment income hidden hidden hidden hidden hidden
Gain (loss) on equity investments hidden hidden hidden hidden hidden
Provision for restructuring hidden hidden hidden hidden hidden
Litigation and other settlements hidden hidden hidden hidden hidden
Equity in net income of affiliates hidden hidden hidden hidden hidden
Divestiture gains hidden hidden hidden hidden hidden
Royalties and licensing income hidden hidden hidden hidden hidden
Transition and other service fees hidden hidden hidden hidden hidden
Pension and postretirement hidden hidden hidden hidden hidden
Intangible asset impairment hidden hidden hidden hidden hidden
Written option adjustment hidden hidden hidden hidden hidden
Loss on debt redemption hidden hidden hidden hidden hidden
Other hidden hidden hidden hidden hidden
Other income (expense), net hidden hidden hidden hidden hidden
Earnings before income taxes hidden hidden hidden hidden hidden
Provision for income taxes hidden hidden hidden hidden hidden
Net earnings hidden hidden hidden hidden hidden
Noncontrolling interest hidden hidden hidden hidden hidden
Net earnings attributable to BMS hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13).

Income statement item Description The company
Operating income The net result for the period of deducting operating expenses from operating revenues. Bristol-Myers Squibb Co.’s operating income as a percentage of revenues decreased from 2016 to 2017 but then increased from 2017 to 2018 not reaching 2016 level.
Earnings before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Bristol-Myers Squibb Co.’s earnings before income taxes as a percentage of revenues decreased from 2016 to 2017 but then slightly increased from 2017 to 2018.
Net earnings attributable to BMS The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Bristol-Myers Squibb Co.’s net earnings attributable to BMS as a percentage of revenues decreased from 2016 to 2017 but then increased from 2017 to 2018 not reaching 2016 level.